A. Garcia-Huerta

A prognostic model for survival after salvage treatment with FLAG‐Ida +/− gemtuzumab‐ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia

M. Sanz, M. Barrios, J. Serrano, 2016, British journal of haematology.